BioSample	Title	Organism	Alias	Antibiotics	Cohort	Description	ENA checklist	INSDC center alias	INSDC center name	INSDC first public	INSDC last update	INSDC status	PFS 3 months	PFS 6 month	Patient ID	Response	SRA accession	Sample Name	Timepoint	Title	collection date	environment (biome)	environment (feature)	environment (material)	geographic location (country and/or sea)	geographic location (latitude)	geographic location (longitude)	host age	host disease status	host sex	human gut environmental package	investigation type	project name	sequencing method
SAMEA104416345	RCC_I_075_T0	human gut metagenome	RCC_I_075_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Below	Below	I_075	Progression	ERS2034287	ERS2034287	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	63	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416344	RCC_I_072_T0	human gut metagenome	RCC_I_072_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_072	Stable	ERS2034286	ERS2034286	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	68	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416343	RCC_I_069_T0	human gut metagenome	RCC_I_069_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_069	Stable	ERS2034285	ERS2034285	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	64	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416342	RCC_I_066_T0	human gut metagenome	RCC_I_066_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Below	Below	I_066	Progression	ERS2034284	ERS2034284	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416341	RCC_I_064_T0	human gut metagenome	RCC_I_064_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_064	Stable	ERS2034283	ERS2034283	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	69	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416340	RCC_I_062_T0	human gut metagenome	RCC_I_062_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_062	Stable	ERS2034282	ERS2034282	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	63	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416339	RCC_I_060_T0	human gut metagenome	RCC_I_060_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_060	Stable	ERS2034281	ERS2034281	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416338	RCC_I_059_T0	human gut metagenome	RCC_I_059_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_059	Partial response	ERS2034280	ERS2034280	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	68	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416337	RCC_I_058_T0	human gut metagenome	RCC_I_058_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_058	Partial response	ERS2034279	ERS2034279	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	69	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416336	RCC_I_057_T0	human gut metagenome	RCC_I_057_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_057	Stable	ERS2034278	ERS2034278	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	82	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416335	RCC_I_055_T1	human gut metagenome	RCC_I_055_T1	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_055	Partial response	ERS2034277	ERS2034277	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	79	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416334	RCC_I_052_T0	human gut metagenome	RCC_I_052_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_052	Stable	ERS2034276	ERS2034276	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	43	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416333	RCC_I_047_T0	human gut metagenome	RCC_I_047_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_047	Partial response	ERS2034275	ERS2034275	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	74	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416332	RCC_I_045_T0	human gut metagenome	RCC_I_045_T0	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_045	Stable	ERS2034274	ERS2034274	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	53	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416331	RCC_I_044_T0	human gut metagenome	RCC_I_044_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Not determined	Not determined	I_044	Stable	ERS2034273	ERS2034273	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416330	RCC_I_043_T0	human gut metagenome	RCC_I_043_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_043	Stable	ERS2034272	ERS2034272	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	42	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416329	RCC_I_042_T0	human gut metagenome	RCC_I_042_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Below	Below	I_042	Dead	ERS2034271	ERS2034271	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	64	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416328	RCC_I_041_T0	human gut metagenome	RCC_I_041_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_041	Partial response	ERS2034270	ERS2034270	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416327	RCC_I_040_T1	human gut metagenome	RCC_I_040_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Below	Below	I_040	Progression	ERS2034269	ERS2034269	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	71	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416326	RCC_I_040_T0	human gut metagenome	RCC_I_040_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Below	Below	I_040	Progression	ERS2034268	ERS2034268	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	71	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416325	RCC_I_039_T1	human gut metagenome	RCC_I_039_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_039	Stable	ERS2034267	ERS2034267	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	64	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416324	RCC_I_039_T0	human gut metagenome	RCC_I_039_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_039	Stable	ERS2034266	ERS2034266	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	64	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416323	RCC_I_038_T2	human gut metagenome	RCC_I_038_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_038	Stable	ERS2034265	ERS2034265	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	68	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416322	RCC_I_038_T0	human gut metagenome	RCC_I_038_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_038	Stable	ERS2034264	ERS2034264	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	68	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416321	RCC_I_036_T1	human gut metagenome	RCC_I_036_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Below	Below	I_036	Progression	ERS2034263	ERS2034263	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	58	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416320	RCC_I_036_T0	human gut metagenome	RCC_I_036_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Below	Below	I_036	Progression	ERS2034262	ERS2034262	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	58	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416319	RCC_I_035_T0	human gut metagenome	RCC_I_035_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Below	Below	I_035	Progression	ERS2034261	ERS2034261	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	58	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416318	RCC_I_034_T2	human gut metagenome	RCC_I_034_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Below	Below	I_034	Stable	ERS2034260	ERS2034260	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	50	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416317	RCC_I_034_T0	human gut metagenome	RCC_I_034_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Below	Below	I_034	Stable	ERS2034259	ERS2034259	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	50	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416316	RCC_I_033_T0	human gut metagenome	RCC_I_033_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_033	Partial response	ERS2034258	ERS2034258	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416315	RCC_I_030_T2	human gut metagenome	RCC_I_030_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_030	Stable	ERS2034257	ERS2034257	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416314	RCC_I_030_T1	human gut metagenome	RCC_I_030_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_030	Stable	ERS2034256	ERS2034256	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416313	RCC_I_030_T0	human gut metagenome	RCC_I_030_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_030	Stable	ERS2034255	ERS2034255	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416312	RCC_I_027_T1	human gut metagenome	RCC_I_027_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_027	Partial response	ERS2034254	ERS2034254	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	58	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416311	RCC_I_025_T2	human gut metagenome	RCC_I_025_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_025	Stable	ERS2034253	ERS2034253	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416310	RCC_I_025_T1	human gut metagenome	RCC_I_025_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_025	Stable	ERS2034252	ERS2034252	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416309	RCC_I_025_T0	human gut metagenome	RCC_I_025_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_025	Stable	ERS2034251	ERS2034251	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416308	RCC_I_023_T2	human gut metagenome	RCC_I_023_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_023	Stable	ERS2034250	ERS2034250	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	73	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416307	RCC_I_023_T0	human gut metagenome	RCC_I_023_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_023	Stable	ERS2034249	ERS2034249	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	73	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416306	RCC_I_021_T2	human gut metagenome	RCC_I_021_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_021	Stable	ERS2034248	ERS2034248	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416305	RCC_I_021_T1	human gut metagenome	RCC_I_021_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_021	Stable	ERS2034247	ERS2034247	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416304	RCC_I_021_T0	human gut metagenome	RCC_I_021_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_021	Stable	ERS2034246	ERS2034246	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416303	RCC_I_020_T2	human gut metagenome	RCC_I_020_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_020	Stable	ERS2034245	ERS2034245	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416302	RCC_I_020_T0	human gut metagenome	RCC_I_020_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_020	Stable	ERS2034244	ERS2034244	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416301	RCC_I_019_T2	human gut metagenome	RCC_I_019_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Below	I_019	Stable	ERS2034243	ERS2034243	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416300	RCC_I_019_T0	human gut metagenome	RCC_I_019_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Below	I_019	Stable	ERS2034242	ERS2034242	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416299	RCC_I_018_T1	human gut metagenome	RCC_I_018_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Below	I_018	Stable	ERS2034241	ERS2034241	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	59	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416298	RCC_I_018_T0	human gut metagenome	RCC_I_018_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Below	I_018	Stable	ERS2034240	ERS2034240	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	59	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416297	RCC_I_017_T0	human gut metagenome	RCC_I_017_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_017	Progression	ERS2034239	ERS2034239	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	65	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416296	RCC_I_016_T1	human gut metagenome	RCC_I_016_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_016	Progression	ERS2034238	ERS2034238	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	52	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416295	RCC_I_016_T0	human gut metagenome	RCC_I_016_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_016	Progression	ERS2034237	ERS2034237	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	52	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416294	RCC_I_015_T0	human gut metagenome	RCC_I_015_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_015	Partial response	ERS2034236	ERS2034236	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	70	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416293	RCC_I_014_T2	human gut metagenome	RCC_I_014_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_014	Partial response	ERS2034235	ERS2034235	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	46	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416292	RCC_I_014_T1	human gut metagenome	RCC_I_014_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_014	Partial response	ERS2034234	ERS2034234	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	46	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416291	RCC_I_014_T0	human gut metagenome	RCC_I_014_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_014	Partial response	ERS2034233	ERS2034233	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	46	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416290	RCC_I_012_T2	human gut metagenome	RCC_I_012_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_012	Progression	ERS2034232	ERS2034232	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	52	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416289	RCC_I_012_T1	human gut metagenome	RCC_I_012_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_012	Progression	ERS2034231	ERS2034231	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	52	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416288	RCC_I_012_T0	human gut metagenome	RCC_I_012_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_012	Progression	ERS2034230	ERS2034230	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	52	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416287	RCC_I_011_T1	human gut metagenome	RCC_I_011_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Below	I_011	Progression	ERS2034229	ERS2034229	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	69	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416286	RCC_I_011_T0	human gut metagenome	RCC_I_011_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Below	I_011	Progression	ERS2034228	ERS2034228	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	69	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416285	RCC_I_009_T2	human gut metagenome	RCC_I_009_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_009	Stable	ERS2034227	ERS2034227	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	70	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416284	RCC_I_009_T1	human gut metagenome	RCC_I_009_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_009	Stable	ERS2034226	ERS2034226	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	70	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416283	RCC_I_009_T0	human gut metagenome	RCC_I_009_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_009	Stable	ERS2034225	ERS2034225	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	70	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416282	RCC_I_008_T0	human gut metagenome	RCC_I_008_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_008	Partial response	ERS2034224	ERS2034224	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416281	RCC_I_007_T1	human gut metagenome	RCC_I_007_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_007	Progression	ERS2034223	ERS2034223	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	70	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416280	RCC_I_007_T0	human gut metagenome	RCC_I_007_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_007	Progression	ERS2034222	ERS2034222	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	70	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416279	RCC_I_006_T0	human gut metagenome	RCC_I_006_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_006	Progression	ERS2034221	ERS2034221	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	43	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416278	RCC_I_004_T2	human gut metagenome	RCC_I_004_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_004	Partial response	ERS2034220	ERS2034220	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416277	RCC_I_004_T0	human gut metagenome	RCC_I_004_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_004	Partial response	ERS2034219	ERS2034219	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416276	RCC_I_002_T2	human gut metagenome	RCC_I_002_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_002	Progression	ERS2034218	ERS2034218	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	41	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416275	RCC_I_002_T1	human gut metagenome	RCC_I_002_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_002	Progression	ERS2034217	ERS2034217	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	41	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416274	RCC_I_002_T0	human gut metagenome	RCC_I_002_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_002	Progression	ERS2034216	ERS2034216	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	41	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416273	RCC_C_014_T0	human gut metagenome	RCC_C_014_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	C_014	Progression	ERS2034215	ERS2034215	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	59	RCC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416272	RCC_I_076_T0	human gut metagenome	RCC_I_076_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_076	Stable	ERS2034214	ERS2034214	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	74	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416271	RCC_I_074_T1	human gut metagenome	RCC_I_074_T1	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_074	Stable	ERS2034213	ERS2034213	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	44	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416270	RCC_I_073_T0	human gut metagenome	RCC_I_073_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_073	Partial response	ERS2034212	ERS2034212	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	76	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416269	RCC_I_070_T0	human gut metagenome	RCC_I_070_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_070	Partial response	ERS2034211	ERS2034211	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	49	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416268	RCC_I_068_T0	human gut metagenome	RCC_I_068_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_068	Progression	ERS2034210	ERS2034210	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	57	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416267	RCC_I_065_T0	human gut metagenome	RCC_I_065_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_065	Stable	ERS2034209	ERS2034209	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	66	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416266	RCC_I_063_T0	human gut metagenome	RCC_I_063_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_063	Progression	ERS2034208	ERS2034208	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	31	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416265	RCC_I_061_T0	human gut metagenome	RCC_I_061_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_061	Stable	ERS2034207	ERS2034207	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	34	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416264	RCC_I_056_T0	human gut metagenome	RCC_I_056_T0	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_056	Progression	ERS2034206	ERS2034206	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416263	RCC_I_054_T1	human gut metagenome	RCC_I_054_T1	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Below	Below	I_054	Progression	ERS2034205	ERS2034205	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	73	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416262	RCC_I_051_T0	human gut metagenome	RCC_I_051_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_051	Stable	ERS2034204	ERS2034204	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416261	RCC_I_049_T0	human gut metagenome	RCC_I_049_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Above	I_049	Stable	ERS2034203	ERS2034203	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	63	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416260	RCC_I_037_T2	human gut metagenome	RCC_I_037_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_037	Stable	ERS2034202	ERS2034202	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	76	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416259	RCC_I_037_T1	human gut metagenome	RCC_I_037_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_037	Stable	ERS2034201	ERS2034201	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	76	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416258	RCC_I_037_T0	human gut metagenome	RCC_I_037_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Not determined	I_037	Stable	ERS2034200	ERS2034200	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	76	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416257	RCC_I_026_T2	human gut metagenome	RCC_I_026_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_026	Stable	ERS2034199	ERS2034199	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416256	RCC_I_026_T1	human gut metagenome	RCC_I_026_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_026	Stable	ERS2034198	ERS2034198	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416255	RCC_I_026_T0	human gut metagenome	RCC_I_026_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:52Z	public	Above	Below	I_026	Stable	ERS2034197	ERS2034197	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416254	RCC_I_022_T0	human gut metagenome	RCC_I_022_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_022	Progression	ERS2034196	ERS2034196	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416253	RCC_I_013_T2	human gut metagenome	RCC_I_013_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_013	Progression	ERS2034195	ERS2034195	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416252	RCC_I_013_T1	human gut metagenome	RCC_I_013_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_013	Progression	ERS2034194	ERS2034194	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416251	RCC_I_013_T0	human gut metagenome	RCC_I_013_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_013	Progression	ERS2034193	ERS2034193	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416250	RCC_I_005_T0	human gut metagenome	RCC_I_005_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_005	Stable	ERS2034192	ERS2034192	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	53	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416249	RCC_I_003_T1	human gut metagenome	RCC_I_003_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_003	Stable	ERS2034191	ERS2034191	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	65	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416248	RCC_I_003_T0	human gut metagenome	RCC_I_003_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_003	Stable	ERS2034190	ERS2034190	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	65	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416247	RCC_I_001_T2	human gut metagenome	RCC_I_001_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Below	I_001	Stable	ERS2034189	ERS2034189	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	77	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416246	RCC_I_001_T0	human gut metagenome	RCC_I_001_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Below	I_001	Stable	ERS2034188	ERS2034188	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	77	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416245	RCC_C_017_T0	human gut metagenome	RCC_C_017_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	C_017	Progression	ERS2034187	ERS2034187	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	75	RCC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416244	NSCLC_I_041_T0	human gut metagenome	NSCLC_I_041_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Below	Below	I_041	Progression	ERS2034186	ERS2034186	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416243	NSCLC_I_035_T0	human gut metagenome	NSCLC_I_035_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Below	Below	I_035	Progression	ERS2034185	ERS2034185	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	63	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416228	NSCLC_I_036_T0	human gut metagenome	NSCLC_I_036_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Above	Not determined	I_036	Stable	ERS2034170	ERS2034170	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	59	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416224	NSCLC_I_061_T0	human gut metagenome	NSCLC_I_061_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_061	Progression	ERS2034166	ERS2034166	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	63	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416223	NSCLC_I_056_T0	human gut metagenome	NSCLC_I_056_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_056	Dead	ERS2034165	ERS2034165	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	59	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416222	NSCLC_I_050_T0	human gut metagenome	NSCLC_I_050_T0	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_050	Progression	ERS2034164	ERS2034164	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	48	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416221	NSCLC_I_053_T0	human gut metagenome	NSCLC_I_053_T0	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_053	Stable	ERS2034163	ERS2034163	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	57	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416210	NSCLC_I_044_T0	human gut metagenome	NSCLC_I_044_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Below	Below	I_044	Dead	ERS2034152	ERS2034152	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	62	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416209	NSCLC_I_076_T0	human gut metagenome	NSCLC_I_076_T0	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_076	Progression	ERS2034151	ERS2034151	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	68	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416208	NSCLC_I_075_T0	human gut metagenome	NSCLC_I_075_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Not determined	I_075	Partial response	ERS2034150	ERS2034150	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416207	NSCLC_I_072_T0	human gut metagenome	NSCLC_I_072_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_072	Dead	ERS2034149	ERS2034149	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	57	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416206	NSCLC_I_070_T0	human gut metagenome	NSCLC_I_070_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_070	Stable	ERS2034148	ERS2034148	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	68	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416205	NSCLC_I_069_T0	human gut metagenome	NSCLC_I_069_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Not determined	I_069	Stable	ERS2034147	ERS2034147	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	62	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416204	NSCLC_I_068_T0	human gut metagenome	NSCLC_I_068_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_068	Partial response	ERS2034146	ERS2034146	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	69	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416203	NSCLC_I_067_T0	human gut metagenome	NSCLC_I_067_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_067	Progression	ERS2034145	ERS2034145	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	63	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416202	NSCLC_I_066_T0	human gut metagenome	NSCLC_I_066_T0	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_066	Progression	ERS2034144	ERS2034144	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	78	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416201	NSCLC_I_060_T0	human gut metagenome	NSCLC_I_060_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_060	Progression	ERS2034143	ERS2034143	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	65	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416200	NSCLC_I_058_T0	human gut metagenome	NSCLC_I_058_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_058	Stable	ERS2034142	ERS2034142	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	76	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416199	NSCLC_I_057_T0	human gut metagenome	NSCLC_I_057_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_057	Progression	ERS2034141	ERS2034141	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416198	NSCLC_I_054_T0	human gut metagenome	NSCLC_I_054_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Above	I_054	Partial response	ERS2034140	ERS2034140	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	69	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416197	NSCLC_I_052_T0	human gut metagenome	NSCLC_I_052_T0	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_052	Progression	ERS2034139	ERS2034139	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	70	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416196	NSCLC_I_051_T1	human gut metagenome	NSCLC_I_051_T1	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_051	Progression	ERS2034138	ERS2034138	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	57	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416195	NSCLC_I_049_T1	human gut metagenome	NSCLC_I_049_T1	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Below	Below	I_049	Progression	ERS2034137	ERS2034137	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416194	NSCLC_I_048_T0	human gut metagenome	NSCLC_I_048_T0	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Below	Below	I_048	Progression	ERS2034136	ERS2034136	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	51	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416193	NSCLC_I_046_T0	human gut metagenome	NSCLC_I_046_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Above	Above	I_046	Partial response	ERS2034135	ERS2034135	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	62	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416192	NSCLC_I_078_T0	human gut metagenome	NSCLC_I_078_T0	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_078	Progression	ERS2034134	ERS2034134	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	63	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416191	NSCLC_I_077_T0	human gut metagenome	NSCLC_I_077_T0	yes	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Below	Below	I_077	Progression	ERS2034133	ERS2034133	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	43	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416190	NSCLC_I_065_T0	human gut metagenome	NSCLC_I_065_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:51Z	public	Above	Not determined	I_065	Partial response	ERS2034132	ERS2034132	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	62	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416189	NSCLC_I_047_T0	human gut metagenome	NSCLC_I_047_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Below	Below	I_047	Progression	ERS2034131	ERS2034131	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416188	NSCLC_I_045_T0	human gut metagenome	NSCLC_I_045_T0	no	validation	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Above	Below	I_045	Stable	ERS2034130	ERS2034130	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	70	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416187	NSCLC_I_039_T0	human gut metagenome	NSCLC_I_039_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Above	Below	I_039	Progression	ERS2034129	ERS2034129	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	76	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416186	NSCLC_I_034_T0	human gut metagenome	NSCLC_I_034_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Above	Not determined	I_034	Stable	ERS2034128	ERS2034128	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	62	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416147	NSCLC_I_040_T0	human gut metagenome	NSCLC_I_040_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Not determined	Not determined	I_040	Partial response	ERS2034089	ERS2034089	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416146	NSCLC_I_038_T0	human gut metagenome	NSCLC_I_038_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2018-01-07T17:02:52Z	2018-01-12T09:57:50Z	public	Not determined	Not determined	I_038	Stable	ERS2034088	ERS2034088	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	62	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416242	NSCLC_I_022_T0	human gut metagenome	NSCLC_I_022_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	I_022	Stable	ERS2034184	ERS2034184	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	66	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416241	NSCLC_I_016_T1	human gut metagenome	NSCLC_I_016_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Above	I_016	Partial response	ERS2034183	ERS2034183	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	65	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416240	NSCLC_I_012_T1	human gut metagenome	NSCLC_I_012_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_012	Progression	ERS2034182	ERS2034182	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	62	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416239	NSCLC_I_005_T1	human gut metagenome	NSCLC_I_005_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	I_005	Stable	ERS2034181	ERS2034181	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	51	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416238	NSCLC_I_004_T1	human gut metagenome	NSCLC_I_004_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_004	Progression	ERS2034180	ERS2034180	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	52	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416237	NSCLC_C_016_T2	human gut metagenome	NSCLC_C_016_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_016	Progression	ERS2034179	ERS2034179	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	47	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416236	NSCLC_C_016_T1	human gut metagenome	NSCLC_C_016_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_016	Progression	ERS2034178	ERS2034178	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	47	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416235	NSCLC_C_016_T0	human gut metagenome	NSCLC_C_016_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_016	Progression	ERS2034177	ERS2034177	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	47	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416234	NSCLC_B_017_T0	human gut metagenome	NSCLC_B_017_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Not determined	B_017	Stable	ERS2034176	ERS2034176	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	69	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416233	NSCLC_B_016_T1	human gut metagenome	NSCLC_B_016_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Below	Below	B_016	Progression	ERS2034175	ERS2034175	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	32	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416232	NSCLC_B_012_T1	human gut metagenome	NSCLC_B_012_T1	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Below	Below	B_012	Stable	ERS2034174	ERS2034174	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	54	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416231	NSCLC_B_006_T1	human gut metagenome	NSCLC_B_006_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Below	Below	B_006	Progression	ERS2034173	ERS2034173	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	48	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416230	NSCLC_B_006_T0	human gut metagenome	NSCLC_B_006_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Below	Below	B_006	Progression	ERS2034172	ERS2034172	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	48	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416229	NSCLC_B_004_T0	human gut metagenome	NSCLC_B_004_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Below	B_004	Stable	ERS2034171	ERS2034171	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416227	NSCLC_I_031_T0	human gut metagenome	NSCLC_I_031_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_031	Dead	ERS2034169	ERS2034169	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	46	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416226	NSCLC_I_006_T1	human gut metagenome	NSCLC_I_006_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Above	I_006	Stable	ERS2034168	ERS2034168	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416225	NSCLC_C_021_T0	human gut metagenome	NSCLC_C_021_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Above	C_021	Partial response	ERS2034167	ERS2034167	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	66	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416220	NSCLC_I_017_T1	human gut metagenome	NSCLC_I_017_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_017	Progression	ERS2034162	ERS2034162	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	76	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416219	NSCLC_I_015_T2	human gut metagenome	NSCLC_I_015_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	I_015	Stable	ERS2034161	ERS2034161	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	74	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416218	NSCLC_I_015_T0	human gut metagenome	NSCLC_I_015_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	I_015	Stable	ERS2034160	ERS2034160	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	74	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416217	NSCLC_I_010_T1	human gut metagenome	NSCLC_I_010_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_010	Progression	ERS2034159	ERS2034159	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416216	NSCLC_I_009_T1	human gut metagenome	NSCLC_I_009_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_009	Progression	ERS2034158	ERS2034158	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	58	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416215	NSCLC_B_013_T1	human gut metagenome	NSCLC_B_013_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Not determined	B_013	Partial response	ERS2034157	ERS2034157	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	66	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416214	NSCLC_B_013_T0	human gut metagenome	NSCLC_B_013_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Not determined	B_013	Partial response	ERS2034156	ERS2034156	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	66	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416213	NSCLC_B_001_T2	human gut metagenome	NSCLC_B_001_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Below	B_001	Stable	ERS2034155	ERS2034155	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416212	NSCLC_B_001_T1	human gut metagenome	NSCLC_B_001_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Below	B_001	Stable	ERS2034154	ERS2034154	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416211	NSCLC_B_001_T0	human gut metagenome	NSCLC_B_001_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Below	B_001	Stable	ERS2034153	ERS2034153	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	60	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416185	NSCLC_I_032_T2	human gut metagenome	NSCLC_I_032_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Not determined	I_032	Partial response	ERS2034127	ERS2034127	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	53	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416184	NSCLC_I_032_T1	human gut metagenome	NSCLC_I_032_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Not determined	I_032	Partial response	ERS2034126	ERS2034126	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	53	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416183	NSCLC_I_032_T0	human gut metagenome	NSCLC_I_032_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Not determined	I_032	Partial response	ERS2034125	ERS2034125	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	53	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416182	NSCLC_I_028_T0	human gut metagenome	NSCLC_I_028_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_028	Dead	ERS2034124	ERS2034124	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416181	NSCLC_I_024_T0	human gut metagenome	NSCLC_I_024_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_024	Dead	ERS2034123	ERS2034123	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	69	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416180	NSCLC_I_021_T1	human gut metagenome	NSCLC_I_021_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_021	Dead	ERS2034122	ERS2034122	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	68	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416179	NSCLC_I_020_T0	human gut metagenome	NSCLC_I_020_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	I_020	Stable	ERS2034121	ERS2034121	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	63	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416178	NSCLC_I_019_T2	human gut metagenome	NSCLC_I_019_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Above	I_019	Partial response	ERS2034120	ERS2034120	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416177	NSCLC_I_019_T1	human gut metagenome	NSCLC_I_019_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Above	I_019	Partial response	ERS2034119	ERS2034119	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416176	NSCLC_I_019_T0	human gut metagenome	NSCLC_I_019_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Above	I_019	Partial response	ERS2034118	ERS2034118	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416175	NSCLC_I_014_T1	human gut metagenome	NSCLC_I_014_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Above	I_014	Partial response	ERS2034117	ERS2034117	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	57	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416174	NSCLC_I_002_T1	human gut metagenome	NSCLC_I_002_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Above	I_002	Stable	ERS2034116	ERS2034116	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	53	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416173	NSCLC_I_001_T2	human gut metagenome	NSCLC_I_001_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	I_001	Stable	ERS2034115	ERS2034115	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	68	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416172	NSCLC_I_001_T1	human gut metagenome	NSCLC_I_001_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	I_001	Stable	ERS2034114	ERS2034114	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	68	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416171	NSCLC_I_001_T0	human gut metagenome	NSCLC_I_001_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	I_001	Stable	ERS2034113	ERS2034113	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	68	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416170	NSCLC_C_011_T2	human gut metagenome	NSCLC_C_011_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	C_011	Stable	ERS2034112	ERS2034112	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	72	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416169	NSCLC_C_011_T1	human gut metagenome	NSCLC_C_011_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	C_011	Stable	ERS2034111	ERS2034111	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	72	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416168	NSCLC_C_011_T0	human gut metagenome	NSCLC_C_011_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	C_011	Stable	ERS2034110	ERS2034110	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	72	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416167	NSCLC_C_007_T2	human gut metagenome	NSCLC_C_007_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	C_007	Stable	ERS2034109	ERS2034109	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	73	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416166	NSCLC_C_007_T1	human gut metagenome	NSCLC_C_007_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	C_007	Stable	ERS2034108	ERS2034108	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	73	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416165	NSCLC_C_007_T0	human gut metagenome	NSCLC_C_007_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Below	C_007	Stable	ERS2034107	ERS2034107	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	73	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416164	NSCLC_C_005_T2	human gut metagenome	NSCLC_C_005_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_005	Progression	ERS2034106	ERS2034106	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416163	NSCLC_C_005_T1	human gut metagenome	NSCLC_C_005_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_005	Progression	ERS2034105	ERS2034105	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416162	NSCLC_C_005_T0	human gut metagenome	NSCLC_C_005_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_005	Progression	ERS2034104	ERS2034104	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416161	NSCLC_C_004_T2	human gut metagenome	NSCLC_C_004_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_004	Progression	ERS2034103	ERS2034103	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	76	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416160	NSCLC_C_004_T1	human gut metagenome	NSCLC_C_004_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Below	Below	C_004	Progression	ERS2034102	ERS2034102	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	76	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416159	NSCLC_C_004_T0	human gut metagenome	NSCLC_C_004_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Below	Below	C_004	Progression	ERS2034101	ERS2034101	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	76	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416158	NSCLC_C_001_T1	human gut metagenome	NSCLC_C_001_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Above	C_001	Stable	ERS2034100	ERS2034100	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	65	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416157	NSCLC_B_015_T1	human gut metagenome	NSCLC_B_015_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Not determined	B_015	Stable	ERS2034099	ERS2034099	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	64	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416156	NSCLC_B_015_T0	human gut metagenome	NSCLC_B_015_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Not determined	B_015	Stable	ERS2034098	ERS2034098	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	64	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416155	NSCLC_B_010_T1	human gut metagenome	NSCLC_B_010_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Below	Below	B_010	Stable	ERS2034097	ERS2034097	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416154	NSCLC_B_009_T0	human gut metagenome	NSCLC_B_009_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Below	Below	B_009	Dead	ERS2034096	ERS2034096	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	67	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416153	NSCLC_B_008_T1	human gut metagenome	NSCLC_B_008_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Below	Below	B_008	Progression	ERS2034095	ERS2034095	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	70	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416152	NSCLC_B_005_T2	human gut metagenome	NSCLC_B_005_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Below	B_005	Stable	ERS2034094	ERS2034094	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	77	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416151	NSCLC_B_005_T1	human gut metagenome	NSCLC_B_005_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Below	B_005	Stable	ERS2034093	ERS2034093	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	77	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416150	NSCLC_B_005_T0	human gut metagenome	NSCLC_B_005_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Above	Below	B_005	Stable	ERS2034092	ERS2034092	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	77	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416149	NSCLC_B_003_T1	human gut metagenome	NSCLC_B_003_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Below	Below	B_003	Progression	ERS2034091	ERS2034091	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	59	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416148	NSCLC_B_002_T1	human gut metagenome	NSCLC_B_002_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:49Z	public	Below	Below	B_002	Progression	ERS2034090	ERS2034090	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	69	NSCLC	male	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416145	NSCLC_I_030_T2	human gut metagenome	NSCLC_I_030_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_030	Progression	ERS2034087	ERS2034087	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	56	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416144	NSCLC_I_030_T1	human gut metagenome	NSCLC_I_030_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_030	Progression	ERS2034086	ERS2034086	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	56	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416143	NSCLC_I_030_T0	human gut metagenome	NSCLC_I_030_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_030	Progression	ERS2034085	ERS2034085	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	56	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416142	NSCLC_I_029_T0	human gut metagenome	NSCLC_I_029_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Above	I_029	Stable	ERS2034084	ERS2034084	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	77	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416141	NSCLC_I_018_T1	human gut metagenome	NSCLC_I_018_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_018	Progression	ERS2034083	ERS2034083	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	48	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416140	NSCLC_I_011_T2	human gut metagenome	NSCLC_I_011_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Above	I_011	Partial response	ERS2034082	ERS2034082	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	73	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416139	NSCLC_I_011_T0	human gut metagenome	NSCLC_I_011_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Above	I_011	Partial response	ERS2034081	ERS2034081	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	73	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416138	NSCLC_I_007_T2	human gut metagenome	NSCLC_I_007_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_007	Progression	ERS2034080	ERS2034080	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416137	NSCLC_I_007_T0	human gut metagenome	NSCLC_I_007_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_007	Progression	ERS2034079	ERS2034079	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	61	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416136	NSCLC_I_003_T1	human gut metagenome	NSCLC_I_003_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	I_003	Progression	ERS2034078	ERS2034078	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	63	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416135	NSCLC_C_020_T0	human gut metagenome	NSCLC_C_020_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Not determined	C_020	Stable	ERS2034077	ERS2034077	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	49	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416134	NSCLC_C_018_T0	human gut metagenome	NSCLC_C_018_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Above	Not determined	C_018	Partial response	ERS2034076	ERS2034076	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	59	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416133	NSCLC_C_015_T0	human gut metagenome	NSCLC_C_015_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_015	Progression	ERS2034075	ERS2034075	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	55	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416132	NSCLC_C_012_T0	human gut metagenome	NSCLC_C_012_T0	yes	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_012	Progression	ERS2034074	ERS2034074	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	62	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416131	NSCLC_C_010_T1	human gut metagenome	NSCLC_C_010_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_010	Progression	ERS2034073	ERS2034073	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	49	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416130	NSCLC_C_010_T0	human gut metagenome	NSCLC_C_010_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_010	Progression	ERS2034072	ERS2034072	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	49	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416129	NSCLC_C_008_T2	human gut metagenome	NSCLC_C_008_T2	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_008	Progression	ERS2034071	ERS2034071	T2	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	77	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416128	NSCLC_C_008_T1	human gut metagenome	NSCLC_C_008_T1	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_008	Progression	ERS2034070	ERS2034070	T1	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	77	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
SAMEA104416127	NSCLC_C_008_T0	human gut metagenome	NSCLC_C_008_T0	no	discovery	Sample for study described in Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	ERC000015	INRA-META	Institut National pour la Recherche Agronomique (FRANCE)	2017-12-05T17:02:53Z	2018-01-12T09:57:50Z	public	Below	Below	C_008	Progression	ERS2034069	ERS2034069	T0	human gut metagenome	2016	city	human-associated habitat	feces	France	48.795496	2.347477	77	NSCLC	female	human-gut	metagenome	Gut microbiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB	Ion-Proton
